Results 291 to 300 of about 279,538 (412)

Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis

Alimentary Pharmacology &Therapeutics, EarlyView.
In a multi‐centre study of obeticholic acid in primary biliary cholangitis, 45% discontinued the drug over 4 years, with 11% moving to combination therapy (fibrates). Of those continuing, response rates increased from 37% (1 year) to 55% (4 years). Non‐response at 12 months and cirrhosis were independent predictors of liver‐related events.
Nadir Abbas, Rachel Smith, Ellina Lytvyak, Miki Scaravaglio, Neil Halliday, Amal Almahroos, Nadia Eden, Diane Lloyd‐Madden, Sanchit Sharma, James Ferguson, Jessica K. Dyson, Douglas Thorburn, David Jones, Aldo J. Montano‐Loza, Marco Carbone, Pietro Invernizzi, George Mells, Emma L. Culver, Palak J. Trivedi   +18 more
wiley   +1 more source

Robotic-Assisted Common Bile Duct Exploration for Choledocholithiasis: A Systematic Review and Meta-Analysis of Efficacy and Safety Outcomes. [PDF]

Cureus
Lee TY, Sim W, Wong Ching Hwai S, Naqvi SA.   +3 more
europepmc   +1 more source

A Population‐Based Matched Cohort Study of Extra‐Digestive Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease

Alimentary Pharmacology &Therapeutics, EarlyView.
This illustration summarises our primary findings highlighting the rising incidence of certain extra‐digestive cancers among persons with IBD over the 25‐year study duration (left), and the relative rates of extra‐digestive cancer incidence and mortality among persons with IBD in recent years (2010–2019) compared to their age‐ and sex‐matched controls (
Sanjay K. Murthy, Faria Ahmed, Michael Pugliese, Monica Taljaard, Parul Tandon, Priscilla Matthews, Gilaad G. Kaplan, Stephanie Coward, Charles N. Bernstein, Eric I. Benchimol, M. Ellen Kuenzig, Laura E. Targownik, Harminder Singh, on behalf of the Canadian Gastro‐Intestinal Epidemiology Consortium (CanGIEC)   +13 more
wiley   +1 more source

Small but mighty: cylindrical transparent cap-assisted cholangioscopic electrohydraulic lithotripsy and stone extraction for the treatment of difficult common bile duct stones. [PDF]

Endoscopy
Li X, Liu WH.
europepmc   +1 more source

Hydatid cyst of common bile duct mimicking type 1 choledochal cyst

, 2007
Utpal De, Mina Basu
openalex   +1 more source

A contemporary map of Fasciola hepatica distribution in sheep and cattle in New South Wales

Australian Veterinary Journal, EarlyView.
Fasciola hepatica is a global threat to livestock production, human health, and food security. Infection causes significant reductions in milk production and quality, feed conversion efficiency, wool quality, and reproductive performance. In New South Wales (NSW), Australia, data on the distribution of F. hepatica are more than 50 years out of date and
SN Vyas, J Mckay‐Demeler, MP Ward, NED Calvani   +3 more
wiley   +1 more source

Age-Related Variation in the Diameter of the Common Bile Duct and Its Association With Anthropometric Parameters: An Ultrasonographic Study in an Eastern Indian Cohort. [PDF]

Cureus
Hela S, Maitra D.
europepmc   +1 more source

Common bile duct

, 2013
Chia Wei Oh, Jeremy Jones, Tariq Walizai
openaire   +1 more source

Functional Difference of MYC and MYCN in Combined Hepatocellular–Cholangiocarcinoma: Regulation of Differentiation by HNF1B

Cancer Science, EarlyView.
Combined hepatocellular–cholangiocarcinoma (cHCC‐CCA) is a tumor consisting of a mixture of hepatocellular carcinoma and intrahepatic cholangiocarcinoma (CCA) components, but the mechanisms of development are poorly understood. The activation of Myc may be implicated in the formation of cHCC‐CCA and this work demonstrates for the first time that Myc ...
Masanori Goto, Masahiro Yamamoto, Hiroki Tanaka, Yumiko Fujii, Kumi Takasawa, Yuki Kamikokura, Masayo Kamikokura, Nobuyuki Kobayashi, Taro Murakami, Yuji Nishikawa, Akira Takasawa   +10 more
wiley   +1 more source

Approaches in treating infiltrative common bile duct cancer: the potential of robotic hepatopancreatoduodenectomy. [PDF]

J Minim Invasive Surg
Jang EJ, Kim KW.
europepmc   +1 more source